Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Dexcom

Is DexCom Stock Underperforming the Nasdaq?

Despite DexCom's lagging performance relative to the Nasdaq Composite over the past year, Wall Street analysts maintain a strong bullish outlook on the stock's prospects.

Key Takeaways From DexCom Analyst Ratings

Key Takeaways From DexCom Analyst Ratings

DexCom (NASDAQ:DXCM) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

The Stelo glucose biosensor changed the way I manage my diabetes - I tested it for two weeks, and here's how it went

The Stelo glucose biosensor changed the way I manage my diabetes - I tested it for two weeks, and here's how it went

The Stelo glucose biosensor is more affordable and accessible, but how well does it work for diabetics?

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Dexcom Glucose Data To Be Integrated With ŌURA Rings

Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help improve consumers' metabolic health.

International Business Times

Your Oura Ring will be able to show you glucose readings in 2025 – thanks to Dexcom integration

The company is now valued at over $5 billion

Are Wall Street Analysts Predicting DexCom Stock Will Climb or Sink?

Despite DexCom’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Nick Jonas wants to 'take bigger risks' as he reflects on 'wild' Jonas Brothers milestone

EXCLUSIVE The singer-songwriter and actor has crammed a lot into his 32 years of life and the ‘incredibly ambitious and driven’ star is determined there will be a lot more to come

Evening Standard

inkl

Read news from The Economist, FT, and more,
with one subscription

Dexcom Pares Steep Losses Despite A Key Exec Departure Amid Stelo Launch

Dexcom Pares Steep Losses Despite A Key Exec Departure Amid Stelo Launch

Dexcom stock closed in the red on Friday after the diabetes devices player beat third-quarter expectations and kept its outlook.

Investors Business Daily

Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits

Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits

Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New Zealand is good news.

The Conversation

Here's What to Expect From DexCom's Next Earnings Report

Here's What to Expect From DexCom's Next Earnings Report

DexCom is poised to announce its third-quarter results later this month, with analysts predicting a double-digit decline in the company's earnings.

Is DexCom Stock Underperforming the S&P 500?

Is DexCom Stock Underperforming the S&P 500?

Despite DexCom’s underperformance compared to the S&P 500 Index over the past year, Wall Street analysts are highly bullish about the stock’s prospects.

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

The Conversation

How Abbott Labs Is Leaning Into Obesity Treatment, And Taking On Dexcom

How Abbott Labs Is Leaning Into Obesity Treatment, And Taking On Dexcom

Abbott Laboratories launched its newest CGM in the U.S. on Thursday. The biosensor named Lingo is the first-ever for people without diabetes.

Investors Business Daily

Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back?

Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back?

Dexcom launched its new continuous glucose monitor on Monday. But the move didn't help troubled Dexcom stock.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Is Wall Street Bullish or Bearish on DexCom Stock?

Despite DexCom lagging behind the broader market over the past year, Wall Street analysts remain bullish on the stock’s prospects.

Investors Business Daily

As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott

The diabetes donnybrook between Abbott Laboratories and Dexcom is poised to heat up — and could bolster both Abbott stock and Dexcom stock.

Stock Market Today: Dow Adds 654 Points as 3M Stock Explodes Higher

It was a risk-on day for stocks thanks to an upbeat inflation reading and impressive earnings from 3M and Deckers.

Midday movers: NVIDIA, Meta, Microsoft up, diabetes stock slumps

Stocks rallied after an encouraging PCE inflation print, but not every company is a winner today.

Get all your
news in one place.

100’s of premium titles.
One news app.

Dexcom Stock Sinks on Sales Miss, Guidance Cut: What to Know

Dexcom stock is crashing Friday after the glucose monitoring company reported dismal Q2 revenue and slashed its full-year sales guidance. Here's what you need to know.

Investors Business Daily

Dow Jones Eases From Highs As S&P 500, Nasdaq Trim Gains (Live Coverage)

The Dow Jones was the strongest performer of the major indexes with help from 3M stock.

Investors Business Daily

Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review

The stock market remained split, with small caps leading and the Nasdaq tumbling, led by Google and Tesla.

Investors Business Daily

Dexcom Stock Crashes 41% After Slashing Its Guidance On A 'Painfully Self-Inflicted' Quarter

Dexcom stock plummeted early Friday after the diabetes devices maker reported light June-quarter sales and slashed its outlook.

Investors Business Daily

Dow Jones Futures Rise As Nvidia Fights AI Fatigue; Fed's Inflation Data Due

Small caps jumped as the Nasdaq and Nvidia fight AI fatigue. ServiceNow broke out. The Fed's key inflation gauge is due.

3 Top-Rated Healthcare Stocks With 20% to 35% Upside Potential

Amid a broader market rotation out of Big Tech stocks, investors can consider these three top-rated healthcare stocks with double-digit upside potential.

Your Apple Watch can track blood sugar levels — here's how with Dexcom G7

Learn to set up and use the Dexcom G7 CGM system with your Apple Watch for convenient, real-time blood sugar monitoring.

1 2 3 4 5

People

Priyanka Chopra

The Jonas Brothers

Margaret Kaczor Andrew

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

243,693 stories

Aotearoa New Zealand

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play